NOTE TO READERS: When this project lost substantial funding at the end of 2018, I lost the ability to continue publishing criteria-driven news story reviews and PR news release reviews - once the bread-and-butter of the site going back to 2006. The 3,200 archived reviews, while still educational, are getting old and difficult for me to technically maintain on the back end of the website. So I am announcing that I plan to remove these reviews from the site by April 1, 2021. The blog and the toolkit - two of the most popular features on the site - will remain. If you wish to peruse the reviews before they disappear, please do so by the end of March 2021. After that date you may still be able to access them via the Internet Archive Wayback Machine - https://archive.org/web/.

Categories: Independent research center news release

3/15/2018

Can bone density scans help assess cardiovascular risk? More details needed in news release

10/17/2017

Announcement on phase 1 leprosy vaccine trial suffers from hyperbole, lack of evidence

5/31/2017

‘Magical’ with ‘superpowers’? This drug to fight antibiotic-resistant infection hasn’t been tested in animals or humans yet.

3/30/2017

Fred Hutch oversells benefit of new fast-tracked drug for rare skin cancer

2 6/21/2016

It’s never OK to use ‘holy grail of breast cancer prevention’ when talking about pre-clinical animal study

6/3/2016

Overly enthusiastic PR release claims breast cancer prevention is “within reach” based on animal, cell culture studies

3/21/2016

News release makes claims about ketamine for depression based on thin evidence

3/15/2016

Nutritional drink to protect memory in ‘early Alzheimer’s’? Release takes us for a spin

1 1/29/2016

Recycled PR release doesn’t tell us anything new about garlic

1/26/2016

Possible new Parkinson’s drug — Novel: Yes. “Breakthrough”: No.

News Release Reviews

Systematic, Criteria-Driven

@HealthNewsRevu

HealthNewsRevuHealthNewsReview.org@HealthNewsRevu·

.@TranspariMED criticizes STAT op-ed for not disclosing pharma funding of author’s institute - similar to criticism we’ve made of STAT op-eds in the past. @transparify @ThinkTankWatch @icer_review https://www.healthnewsreview.org/2021/02/transparency-watchdog-criticizes-stats-non-disclosure-on-pro-pharma-op-ed/

Reply on Twitter 1360214949704982532Retweet on Twitter 13602149497049825323Like on Twitter 13602149497049825328Twitter 1360214949704982532
Retweet on TwitterHealthNewsReview.org Retweeted
ContentScienceContent Science@ContentScience·

If you’re covering COVID-19, you need a robust understanding of how to report on health and science news (and when you're in over your head). Get a leg up with these insights from @garyschwitzer.

https://review.content-science.com/health-and-science-communication-in-the-covid-era-a-qa-with-the-publisher-of-health-news-review/

Reply on Twitter 1359955873561518085Retweet on Twitter 13599558735615180852Like on Twitter 13599558735615180851Twitter 1359955873561518085
HealthNewsRevuHealthNewsReview.org@HealthNewsRevu·

Tech sites @MacRumors & @TechCrunch hype #AppleWatch’s ability to predict #COVID19 without providing the evidence. @mtmdphd was keen observer. https://www.healthnewsreview.org/2021/02/tech-sites-hype-apple-watch-for-covid-19-prediction-without-providing-the-evidence/

Reply on Twitter 1359860468135964683Retweet on Twitter 13598604681359646832Like on Twitter 13598604681359646834Twitter 1359860468135964683
View More

Categories

View More

Tags